Siyu Zeng

C/EBPβ knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFκB

J. Zou, Hong Li, Peiqing Liu, 2014, Molecular and Cellular Endocrinology.

Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4

Suowen Xu, J. Zou, Peiqing Liu, 2013, Molecular and Cellular Endocrinology.

Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.

X. Chen, J. Zou, Peiqing Liu, 2013, The Canadian journal of cardiology.

Rapamycin Attenuated Cardiac Hypertrophy Induced by Isoproterenol and Maintained Energy Homeostasis via Inhibiting NF-κB Activation

X. Chen, J. Zou, Peiqing Liu, 2014, Mediators of inflammation.

The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway.

Rong Chen, Juming Yu, Xinyue Qin, 2017, Biochemical and biophysical research communications.

TIEG1 Inhibits Angiotensin II–induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4

Peiqing Liu, Qin Li, Siyu Zeng, 2015, Journal of cardiovascular pharmacology.

Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides.

Min Li, Zhuoming Li, Peiqing Liu, 2015, Archives of biochemistry and biophysics.

Asperosaponin VI protects mice from sepsis by regulating Hippo and Rho signaling pathway.

Chonghua He, Siyu Zeng, Yanxiang Liang, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

TIEG1 Inhibits Angiotensin II–induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4

Peiqing Liu, Qin Li, Siyu Zeng, 2015, Journal of cardiovascular pharmacology.